Li et al., 2024 - Google Patents
Biphasic calcium phosphate recruits Tregs to promote bone regenerationLi et al., 2024
- Document ID
- 4735361316079094559
- Author
- Li J
- Xia T
- Zhao Q
- Wang C
- Fu L
- Zhao Z
- Tang Z
- Yin C
- Wang M
- Xia H
- Publication year
- Publication venue
- Acta Biomaterialia
External Links
Snippet
The use of bone substitute materials is crucial for the healing of large bone defects. Immune response induced by bone substitute materials is essential in bone regeneration. Prior research has mainly concentrated on innate immune cells, such as macrophages. Existing …
- 210000003289 regulatory T cell 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kang et al. | Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization | |
| Dajnoki et al. | Sebaceous gland-rich skin is characterized by TSLP expression and distinct immune surveillance which is disturbed in rosacea | |
| Wendler et al. | Immune Modulation to enhance bone healing—a new concept to induce bone using prostacyclin to locally modulate immunity | |
| Hänel et al. | Control of the physical and antimicrobial skin barrier by an IL-31–IL-1 signaling network | |
| JP7389151B2 (en) | Use of CaMK4 inhibitors in the manufacture of drugs for the treatment of psoriasis | |
| Sharif et al. | Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: a randomized, double-blind, placebo-controlled trial | |
| Li et al. | Biphasic calcium phosphate recruits Tregs to promote bone regeneration | |
| Cho et al. | Th17 cell-mediated immune responses promote mast cell proliferation by triggering stem cell factor in keratinocytes | |
| Cai et al. | Breast cancer cells promote self-migration by secreting interleukin 8 to induce NET formation | |
| Kosaric et al. | Macrophage subpopulation dynamics shift following intravenous infusion of mesenchymal stromal cells | |
| Zhang et al. | Regulatory T cells were recruited by CCL3 to promote cryo-injured muscle repair | |
| Kang et al. | Macrophage control of incipient bone formation in diabetic mice | |
| KR102100307B1 (en) | Isolation and use of human lymphoid organ-derived suppressive stromal cells | |
| Shi et al. | Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function | |
| Yin et al. | Protective effects of CXCR3/HO‑1 gene‑modified BMMSCs on damaged intestinal epithelial cells: Role of the p38‑MAPK signaling pathway | |
| He et al. | Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model | |
| Guzman et al. | Removal of p16 INK4 expressing cells in late life has moderate beneficial effects on skeletal muscle function in male mice | |
| KR20150026839A (en) | Mesenchymal stem cells overexpressing sRAGE and cell therapeutic agent for preventing or treating immune disease | |
| He et al. | Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway | |
| Zheng et al. | Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice | |
| US11819535B2 (en) | Composition and methods for regulating extracellular matrix accumulation | |
| Wen et al. | Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease | |
| CN115120615B (en) | Application of miR-146a-5p overexpression engineering stem cell exosome in preparation of medicines for treating mustard gas-induced lung injury | |
| Li et al. | The homing of exogenous hair follicle mesenchymal stem cells into hair follicle niches | |
| Zhang et al. | Bone marrow mesenchymal stem cells suppress activated CD4+ T cells proliferation through TGF-beta and IL10 dependent of autophagy in pathological hypoxic microenvironment |